Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIKAL. vs PARMAX PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    HIKAL. PARMAX PHARMA HIKAL./
PARMAX PHARMA
 
P/E (TTM) x 45.5 -2.6 - View Chart
P/BV x 2.9 1.8 158.2% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 HIKAL.   PARMAX PHARMA
EQUITY SHARE DATA
    HIKAL.
Mar-23
PARMAX PHARMA
Mar-23
HIKAL./
PARMAX PHARMA
5-Yr Chart
Click to enlarge
High Rs45658 792.0%   
Low Rs21626 818.4%   
Sales per share (Unadj.) Rs164.130.2 544.1%  
Earnings per share (Unadj.) Rs6.4-0.2 -3,117.4%  
Cash flow per share (Unadj.) Rs15.23.5 436.7%  
Dividends per share (Unadj.) Rs1.200-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs91.911.5 800.6%  
Shares outstanding (eoy) m123.305.10 2,417.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.01.4 147.1%   
Avg P/E ratio x52.8-205.9 -25.7%  
P/CF ratio (eoy) x22.112.1 183.2%  
Price / Book Value ratio x3.73.7 99.9%  
Dividend payout %18.90-   
Avg Mkt Cap Rs m41,420214 19,345.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,22428 7,907.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m20,230154 13,154.5%  
Other income Rs m540 13,525.0%   
Total revenues Rs m20,284154 13,156.3%   
Gross profit Rs m2,57123 11,400.0%  
Depreciation Rs m1,09019 5,801.6%   
Interest Rs m4814 13,000.3%   
Profit before tax Rs m1,0540 229,054.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2702 17,988.7%   
Profit after tax Rs m784-1 -75,367.3%  
Gross profit margin %12.714.7 86.7%  
Effective tax rate %25.6326.5 7.8%   
Net profit margin %3.9-0.7 -572.6%  
BALANCE SHEET DATA
Current assets Rs m9,68375 12,860.8%   
Current liabilities Rs m6,90871 9,679.4%   
Net working cap to sales %13.72.6 537.8%  
Current ratio x1.41.1 132.9%  
Inventory Days Days264 576.5%  
Debtors Days Days80147,800 0.1%  
Net fixed assets Rs m15,02497 15,508.0%   
Share capital Rs m24745 554.0%   
"Free" reserves Rs m11,08814 78,918.9%   
Net worth Rs m11,33559 19,355.7%   
Long term debt Rs m4,89945 10,937.2%   
Total assets Rs m24,707176 14,027.7%  
Interest coverage x3.21.1 283.8%   
Debt to equity ratio x0.40.8 56.5%  
Sales to assets ratio x0.80.9 93.8%   
Return on assets %5.11.5 339.6%  
Return on equity %6.9-1.8 -389.1%  
Return on capital %9.54.0 235.0%  
Exports to sales %67.60-   
Imports to sales %25.60-   
Exports (fob) Rs m13,684NA-   
Imports (cif) Rs m5,184NA-   
Fx inflow Rs m13,6840-   
Fx outflow Rs m5,1840-   
Net fx Rs m8,5000-   
CASH FLOW
From Operations Rs m3,1533 94,687.4%  
From Investments Rs m-2,923-9 31,232.9%  
From Financial Activity Rs m-77NA 17,454.5%  
Net Cashflow Rs m153-6 -2,363.1%  

Share Holding

Indian Promoters % 68.9 30.8 223.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.3 0.0 -  
FIIs % 6.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 31.2 69.2 45.0%  
Shareholders   74,657 2,002 3,729.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare HIKAL. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on HIKAL CHEMIC vs PARMAX PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

HIKAL CHEMIC vs PARMAX PHARMA Share Price Performance

Period HIKAL CHEMIC PARMAX PHARMA S&P BSE HEALTHCARE
1-Day -0.32% -0.52% 1.18%
1-Month -5.59% -6.90% -0.75%
1-Year -1.73% 3.34% 61.82%
3-Year CAGR 22.14% -7.09% 18.16%
5-Year CAGR 9.01% 10.48% 19.79%

* Compound Annual Growth Rate

Here are more details on the HIKAL CHEMIC share price and the PARMAX PHARMA share price.

Moving on to shareholding structures...

The promoters of HIKAL CHEMIC hold a 68.9% stake in the company. In case of PARMAX PHARMA the stake stands at 30.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of HIKAL CHEMIC and the shareholding pattern of PARMAX PHARMA.

Finally, a word on dividends...

In the most recent financial year, HIKAL CHEMIC paid a dividend of Rs 1.2 per share. This amounted to a Dividend Payout ratio of 18.9%.

PARMAX PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of HIKAL CHEMIC, and the dividend history of PARMAX PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.